Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: How harmful is it?

Blood Purification

Volumn 31, Issue 1-3, 2011, Pages 102-106

  Perna, Alessandra F ^a   Lanza, Diana ^a   Sepe, Immacolata ^a   Raiola, Ilaria ^a   Capasso, Rosanna ^a   De Santo, Natale G ^a   Ingrosso, Diego ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cystathionine lyase; Diabetes; Hemodialysis; Hydrogen sulfide; Hypertension

Indexed keywords

3 MERCAPTOPYRUVIC ACID; CYSTATHIONINE BETA LYASE; CYSTATHIONINE GAMMA LYASE; HOMOCYSTEINE; HYDROGEN SULFIDE; SULFHEMOGLOBIN;

ATHEROSCLEROSIS; CONFERENCE PAPER; DIABETES MELLITUS; DNA POLYMORPHISM; GENE EXPRESSION; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; METABOLISM; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; STOMACH ULCER; UREMIA;

CARDIOVASCULAR SYSTEM; CYSTATHIONINE GAMMA-LYASE; HUMANS; HYDROGEN SULFIDE; HYPERTENSION; RENAL DIALYSIS; UREMIA;

EID: 78651465332     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321838     Document Type: Conference Paper

References (33)

1. Gadalla MM, Snyder SH: Hydrogen sulfide as a gasotransmitter. J Neurochem DOI: 10.1111/j.1471-4159.2010.06580.x.
2. Kimura H: Hydrogen sulfide: its production, release and functions. Amino Acids DOI: 10.1007/s00726-010-0510-x.
3. Lefer DJ: A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci USA 2007; 104: 17907-17908.
4. Szabo C: Hydrogen sulphide and its therapeutic potential. Nat Rev 2007; 6: 917-935.
5. Li L, Moore PK: Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci 2008; 29: 84-90.
6. Tripatara P, Patel NSA, Collino M, Gallicchio M, Kieswich J, Castiglia S, Benedetti E, Stewart KN, Brown PAJ, Yaqoob MM, Fantozzi R, Thiemermann C: Generation of endogenous hydrogen sulfide by cystathionine γ-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88: 1038-1048.
7. Xia M, Chen L, Muh RW, Li PL, Li N: Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther 2009; 329: 1056-1062.
8. Wu N, Siow YL, Karmin O: Ischemia/reperfusion reduces transcription factor SP1 mediated cystathionine beta-synthase expression in the kidney. J Biol Chem DOI: 10.1074/ jbc.M110.132142.
9. Beltowski J: Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther DOI: 10.1124/ jpet.110.166637.
10. Chen X, Jhee K, Kruger WD: Production of the neuromodulator H 2 S by cystathionine β- synthase via the condensation of cysteine and homocysteine. J Biol Chem 2004; 279: 52082-52086.
11. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H: Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 2009; 146: 623-626.
12. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller JE, Kraus DW: Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 2007; 104: 17977-17982.
13. Budoff MJ, Ahmadi N, Gul KM, Liu ST, Flores FR, Tiano J, Takasu J, Miller E, Tsimikas S: Aged garlic extract supplemented with B vitamins, folic acid and L -arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med 2009; 49: 101-107.
14. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, and Wang R: H 2 S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
15. Perna AF, Luciano MG, Ingrosso D, Raiola I, Pulzella P, Sepe I, Lanza D, Violetti E, Capasso R, Lombardi C, De Santo NG: Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients. J Ren Nutr 2010; 20(suppl):S11-S14.
16. Lu M, Liu Y, Goh HS, Wang JJ, Yong QC, Wang R, Bian JS: Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 2010; 21: 993-1002.
17. Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, Tang X, Ren Y, Tang X, Du J: Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2008; 29: 173-179.
18. D'Emanuele di Villa Bianca R, Sorrentino R, Maffia P, Mirone V, Imbimbo C, Fusco F, De Palma R, Ignarro LJ, Cirino G: Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc Natl Acad Sci USA 2009; 106: 4513-4518.
19. Wu L, Yang W, Jia X, Yang G, Duridanova D, Cao K, Wang R: Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. Lab Invest 2009; 89: 59-67.
20. Ali MY, Whiteman M, Low CM, Moore PK: Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway. J Endocrinol 2007; 195: 1205-1212.
21. Yang G, Yang W, Wu L, Wang R: H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting beta cells. J Biol Chem 2007; 292: 16567-16576.
22. Brancaleone V, Roviezzo F, Velleco V, De Gruttola L, Bucci M, Cirino G: Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol 2008; 155: 673-680.
23. Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE, Shore AC: Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulfide. Diabetologia 2010; 53: 1722-1726.
24. Sen U, Basu P, Abe OA, Givvimani S, Tyagi N, Metreveli N, Shah KS, Passmore JC, Tyagi SC: Hydrogen sulfide ameliorates hyperhomocysteinemia- associated chronic renal failure. Am J Physiol Ren Physiol 2009; 297:F410-F419.
25. Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, Bocchini JA: Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 2010; 12: 1333-1337.
26. Kaneko Y, Kimura Y, Kimura H, Niki I: L - cysteine inhibits insulin release from the pancreatic beta-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter. Diabetes 2006; 55: 1391-1397.
27. Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, Barrow RK, Yang G, Wang R, Snyder SH: H 2 S signals through protein Ssulfhydration. Sci Signal 2009; 2:ra72.
28. Perna AF, Ingrosso D, Violetti E, Luciano MG, Sepe I, Lanza D, Capasso R, Ascione E, Raiola I, Lombardi C, Stenvinkel P, Massy Z, De Santo NG: Hyperhomocysteinemia in uremia - a red flag in a disrupted circuit. Semin Dial 2009; 22: 351-356.
29. Perna AF, Luciano MG, Ingrosso D, Pulzella P, Sepe I, Lanza D, Violetti E, Capasso R, Lombardi C, De Santo NG: Hydrogen sulphide- generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol Dial Transplant 2009; 24: 3756-3763.
30. Elsey DJ, Fowkes RC, Baxter GF: Regulation of cardiovascular cell function by hydrogen sulfide (H 2 S). Cell Biochem Funct DOI: 10.1002/cbf.1618.
31. Bos EM, Leuvenink HGD, Snijder PM, Kloosterhuis NJ, Hillebrands J, Leemans JC, Florquin S, van Goor H: Hydrogen sulfideinduced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 2009; 20: 1901-1905.
32. Chiku T, Dominique Padovani D, Zhu W, Singh S, Vitvitsky V, Banerjee R: H 2 S biogenesis by human cystathionine γ-lyase leads to the novel sulfur metabolites lanthionine and homolanthionine and is responsive to the grade of hyperhomocysteinemia. J Biol Chem 2009; 284: 11601-11612.
33. Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, Pagliaro P: Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Biophys Acta 2009; 1787: 864-872.